| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |